Reversal of Hyperglycemia and Suppression of Type 1 Diabetes in the NOD Mouse with Apoptotic DNA Immunotherapy™ (ADi™), ADi-100

The antigen-specific apoptotic DNA immunotherapeutic, ADi-100, is designed to suppress type 1 diabetes and consists of two DNA plasmids encoding genetic sequences of the apoptosis-inducing molecule, BAX, and the secreted form of the autoantigen, glutamic acid decarboxylase 65, that is CpG hyper-meth...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: David G. Alleva, Melika Rezaee, Linda Yip, Gang Ren, Jarrett Rosenberg, Waldo Concepcion, Alan Escher, Shahrokh Shabahang, Avnesh S. Thakor
Format: Artigo
Langue:Inglês
Publié: MDPI AG 2020-03-01
Collection:Biomedicines
Sujets:
diabetes
immunotherapy
hyperglycemia
dna immunotherapy
nod mouse
type 1 diabetes
antigen-specific
dna plasmids
adi-100
monotherapy
apoptosis
bax
t cells
sgad55
pre-diabetic mouse
Accès en ligne:https://www.mdpi.com/2227-9059/8/3/53
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires